LifeMine Therapeutics is reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere. Through its proprietary, evolutionarily-derived genomic drug discovery platform, LifeMine aims to bring unparalleled speed, predictability and scalability to small molecule drug discovery. LifeMine has discovered, in genomic space, hundreds of potentially high-impact drug candidates relevant to targets across all major disease areas, and has an initial focus on advancing highly impactful precision medicines in oncology and immune modulation. The Company was founded in 2017 by renowned entrepreneur/scientists Gregory Verdine, Ph.D., and Richard Klausner, M.D., and entrepreneur/company-builder WeiQing Zhou.
View Top Employees from LifeMine TherapeuticsWebsite | http://www.lifeminetx.com |
Revenue | $33 million |
Funding | $110 million |
Employees | 140 (140 on RocketReach) |
Founded | 2017 |
Address | 30 Acorn Park Dr, Cambridge, Massachusetts 02140, US |
Phone | (617) 665-5000 |
Technologies |
JavaScript,
HTML,
Twitter
+20 more
(view full list)
|
Industry | Biotechnology, Drug Manufacturing & Research, Pharmaceuticals, Healthcare, Medical Testing & Clinical Laboratories |
Web Rank | 4 Million |
Keywords | Drug Development And Manufacturing, Therapeutic Activities, Oncology, Genetic Testing |
Competitors | Axial Therapeutics, Inc., Eligo Bioscience, Second Genome Inc., SynDevRx, Inc., Vedanta Biosciences, Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325413 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular LifeMine Therapeutics employee's phone or email?
The LifeMine Therapeutics annual revenue was $33 million in 2024.
140 people are employed at LifeMine Therapeutics.
LifeMine Therapeutics is based in Cambridge, Massachusetts.
The NAICS codes for LifeMine Therapeutics are [325413, 32, 3254, 325, 32541].
The SIC codes for LifeMine Therapeutics are [283, 28].